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Abstract 
The effects of exogenous prostaglandins, inflammatory mediators known to be increased in pancreatic 13-cells by IL-113, on the 
replication and long-term insulin secretion by [3-cells were investigated. Prostaglandins E I, E 2, and F2, ~ suppressed 13-cell proliferation 
and long-term insulin secretion, thus mimicking the effects of IL- 113. The actions of prostaglandins were not prevented by pertussis toxin 
pretreatment. Additionally, the cyclooxygenase inhibitor indomethacin could not prevent he effects of IL-113. It is concluded that 
prostaglandins suppress 13-cell growth and long-term insulin secretion without participation of pertussis-toxin sensitive GTP-binding 
proteins. In addition, although their synthesis i  increased by IL-113, prostaglandins seemingly do not convey the inhibitory actions of this 
cytokine in the 13-ce11. 
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1. Introduction 
Despite the potential importance of an insufficient ex- 
tent of ~-cell replication in diabetes, not much is known 
about the intracellular mechanisms that normally govern 
this event, although some extracellular factors stimulating 
13-cell DNA synthesis in vitro have been identified (re- 
viewed in [1-4]). Far less attention has been paid to the 
factors that inhibit [3-cell function and mitosis, in spite of 
the fact that such factors may be of regulatory significance. 
Much interest has been focused on interleukin-l[3 (IL-113), 
a cytokine known to be produced by islet-infiltrating 
macrophages preceding the onset of type-1 diabetes melli- 
tus [5-7]. IL-I[3 exerts cytotoxic and suppressive actions 
on the 13-cell in vitro and is believed to occupy a pivotal 
role in triggering the outbreak of type-1 diabetes mellitus, 
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which is characterized by progressive necrosis of the 13-cells 
by autoimmune processes [8]. IL-113 is known to increase 
the production of prostaglandins, eicosanoids believed to 
be involved in mediating the inflammatory response by 
IL-113 [9-12]. In the rodent 13-cell, IL-113 was shown to 
activate cyclooxygenase in vitro, possibly through nitric 
oxide generation [13]. In intact animals and in humans, 
prostaglandin infusion impeded the insulin secretory re- 
sponse to an intravenous glucose load [14,15]. Conversely, 
certain inhibitors of prostaglandin synthesis have been 
reported to augment glucose-induced insulin responses in 
normal humans, and to exert beneficial actions on 
glucose-sensitive insulin secretion and glucose disposal 
rates in patients with type-II diabetes mellitus [14,15]. In 
this paper, we investigated the long-term impact of prosta- 
glandins on 13-cell mitogenesis and insulin secretion, and 
determined whether they interfere with signaling through 
pertussis toxin-sensitive heterotrimeric GTP-binding pro- 
teins. We also addressed the issue whether prostaglandin 
synthesis is an obligatory step in IL-113 signaling in the 
13-cell. 
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2. Materials and methods 
2.1. Materials 
Prostaglandins were graciously donated by the Upjohn 
Company, Kalamazoo, MI, USA, whereas indomethacin 
and pertussis toxin (PTX) were from Sigma Chemical Co., 
St. Louis, MO, USA. Recombinant human interleukin-l[3 
(IL-I[3) was kindly given by Dr. Klaus Bendtzen, Labora- 
tory of Medical Immunology, Rigshospitalet, University 
Hospital, Copenhagen, Denmark. The biological activity of 
the IL-I[3 was 5 U/pg, as determined by comparison with 
an interim intemational standard IL-I[3 preparation 
(NIBSC, London, UK) in the mouse thymocyte costimula- 
tory assay and the EL4 murine T-cell line. The endotoxin 
content after adding the inlerleukin at the highest concen- 
tration (25 U/ml)  was < 1 pg/ml, as measured in the 
Limulus amoebocyte assay. We have previously found that 
neither 1 pg/ml nor 10 pg/ml of endotoxin affected the 
growth or viability of insulin-producing cells [16]. Collage- 
nase type CLS (EC 3.4.24.3) was obtained from 
Boehringer-Mannheim, Mannheim, Germany. Culture 
medium RPMI 1640, fetal calf serum, L-glutamine, ben- 
sylpenicillin and streptomycin were from Flow Laborato- 
ries, Irvine, UK. Antiporcine insulin serum was raised in 
guinea pigs in our laboratory. Crystalline rat insulin was 
from Novo, Copenhagen, Denmark, whereas porcine 125I- 
insulin was made in our laboratory. [methyl-3H]Thymidine 
(5 Ci/mmol) was purchased from Amersham Intema- 
tional, Bucks., UK. Unisolve was from New England 
Nuclear, Boston, MA, USA and Soluene was provided by 
Packard Instruments, Downers Grove, IL, USA. All other 
chemicals of analytical grade were obtained from E. Merck, 
Darmstadt, Germany. 
of solvent. Fetal islets prepared by this method differenti- 
ate in culture into functionally mature islets containing 
90% ~-cells which are fully responsive not only to 
glucose stimulation of insulin release, but also suppression 
by IL-l[3 [19]. 
2.3. DNA synthesis 
Islets in groups of 50 were cultured for 24 h as de- 
scribed above. During the last 5 h, 1 ixCi/ml of [methyl- 
3 H]thymidine was present in culture media. At the end of 
the labeling period the islets were washed in PBS, ultra- 
sonically homogenized in redistilled water, and precipi- 
tated in ice-cold 10% trichloroacetic acid. The precipitate 
was washed twice in trichloroacetic acid and dissolved in 
50 Ixl of Soluene. The radioactivity incorporated was 
determined by scintillation counting after addition of 1 ml 
of Unisolve. Given the long cell cycle of the 13-cell [20] 
and the fact that unsynchronized cells were studied, it was 
considered necessary to expose the islets for 24 h to the 
different test substances, a procedure that allows DNA 
synthesis initiated prior to addition of test substances to be 
terminated before [3H]thymidine addition. 
2.4. Insulin secretion 
The insulin content in islets homogenized by ultrasonic 
disruption in redistilled water was extracted at 4°C 
overnight in 70% ethanol containing 0.18 M HC1 [21], and 
insulin secretion into culture media during the last 24 h of 
culture were determined radioimmunologically [22]. 
3. Results 
2.2. Preparation and culture of  fetal islets 
Pregnant Sprague-Dawley rats belonging to a local 
stock were killed by cervical dislocation on day 21 of 
gestation and the fetuses rapidly removed. Fetal rat islets 
were prepared from pancreatic glands as previously de- 
scribed [17-19]. Briefly, the pancreata were finely chopped 
and digested for a short time with collagenase. The care- 
fully washed digest was plated in culture dishes allowing 
cell attachment (Nunc, Roskilde, Denmark) and cultured 
for 5 days at 37°C in a humidified atmosphere of 5% CO 2 
in ambient air in medium RPMI 1640 containing 11.1 mM 
glucose, 10% fetal calf serum, 2 mM L-glutamine, 100 
U/ml bensylpenicillin and 0.1 mg/ml streptomycin. At 
the end of the culture period, groups of islets were trans- 
ferred to fresh media containing 1% fetal calf serum and 
cultured free-floating over-night, a procedure that mini- 
mizes fibroblast proliferation. Spherical islets, free of con- 
nective tissue, were then selected under a stereo micro- 
scope and used for the different analyses listed below. In 
each experiment, all test groups received the same amount 
As shown in Fig. 1, exogenous prostaglandins (10 IxM) 
type E 1 and E 2 significantly inhibited fetal rat pancreatic 
13-cell mitogenesis in vitro. PGE1 and PGE 2 caused a 
25% decrease in DNA synthesis, as assessed by pulse- 
labeling of [ 3 H]thymidine into DNA. Similarly, both E-type 
prostaglandins suppressed long-term insulin secretion into 
the culture media over 24 h, whereas PGF2~ was virtually 
inactive on both 13-cell mitogenesis and insulin secretion. 
Given the lability of prostaglandins, I deliberately started 
out with a high concentration that in other studies [14,15] 
has been shown to be maximally effective in suppressing 
[3-cell function. 
It should be noted from Fig. 2 (in which all islets were 
pretreated with pertussis toxin), that, in this long-term 
setting, pertussis toxin was unable to significantly reverse 
the suppressive ffects of PGE 1 and PGE 2 on 13-cell 
proliferation and insulin secretion. Curiously, pertussis 
toxin pretreatment seemed to unmask an inhibitory action 
of PGF2~ not noticed in the absence of the toxin. It should 
be noted (see Figure legends) that the basal rates of DNA 
synthesis (P  < 0.05 in a paired Student's t-test) and in- 
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Fig. 1. Prostaglandins inhibit pancreatic [3-cell mitogenesis and insulin 
secretion. Groups of 50 fetal rat islets were cultured free-floating for 24 h 
in medium RPMI 1640 containing 1% fetal calf serum and supplemented 
as indicated in the figure. During the final 5 h of culture, 1 IxCi/ml 
[3H]thymidine was present in culture media and DNA synthesis rates 
were determined by measuring the radioactivity incorporated into tri- 
chloroacetic acid-precipitable material. Insulin secretion to the culture 
media was determined radioimmunologically. Prostaglandins (PGE~, 
PGE 2 and PGF~,~) were used at 10 p,M. Bars represent mean % of 
controls_+S.E.M, for 10-15 observations. *, * * and ~ * * denote P < 
0.05, P < 0.01 and P < 0.001, respectively, for chance differences vs. 
control islets using Student's paired t-test. Absolute values in control 
islets were 2736_+807 cpm/50 islets (DNA synthesis) and 664_+ 100 
ng/50 islets per ml × 24 h (insulin secretion). 
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Fig. 2. Prostaglandins inhibit 13-cell ong-term function by pertussis 
toxin-insensitive mechanisms. Groups of 50 fetal rat islets were cultured 
free-floating for 24 h in medium RPMI 1640 containing 1% fetal calf 
serum and supplemented as indicated in the Figure. All groups were 
pretreated with pertussis toxin. Islets were treated with the toxin for 24 h 
(and throughout the entire culture period) to ensure that the effects of the 
toxin were expressed. During the final 5 h of culture, 1 IxCi/ml 
[3H]thymidine was present in culture media and DNA synthesis rates 
were determined by measuring the radioactivity incorporated into tri- 
chloroacetic acid-precipitable material. Insulin secretion to the culture 
media was determined radioimmunologically. Prostaglandins (PGE I , 
PGEz and PGF2, ~) were used at 10 IxM, while pertussis toxin was used at 
50 ng/ml. Bars represent mean % of controls+S.E.M, for 5 observa- 
tions. * and * * denote P < 0.05 and P < 0.01, respectively, for chance 
differences vs. control islets using Student's paired t-test. Absolute values 
in control islets were 4605+ 1717 cpm/50 islets (DNA synthesis) and 
1837 _+ 343 ng/50 islets per ml × 24 h (insulin secretion). 
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Fig. 3. Prostaglandins do not mediate the inhibitory effects of IL-l[3 in 
the 13-ce11. Groups of 50 fetal rat islets were cultured free-floating for 24 
h in medium RPMI 1640 containing 1% fetal calf serum and supple- 
mented as indicated in the figure. During the final 5 h of culture, 1 
IxCi/ml [3H]thymidine was present in culture media and DNA synthesis 
rates were determined by measuring the radioactivity incorporated into 
trichloroacetic acid-precipitable material. Insulin secretion to the culture 
media was determined radioimmunologically. Interleukin- 113 (IL- 1 !3) was 
used at 25 U/ml while indomethacin (Indo) was used at 10 txM. Bars 
represent mean % of controls_+ S.E.M. for 5 observations. ~ ~ and * ~ 
denote P < 0.01 and P < 0.001, respectively, for chance differences vs. 
control islets using Student's paired t-test. 
sul in secretion (P  < 0.05 in a paired Student 's  t-test) were 
signif icantly h igher  in pertussis toxin-treated islets, a phe- 
nomenon noted previously [19] and possibly related to an 
increase in islet cycl ic AMP content.  
It is ev ident  f rom Fig. 3, that 24 h of  exposure to IL- 113 
(25 U /ml )  caused a = 50% reduct ion in [3-cell prolifera- 
t ion and insul in secretion, thus conf i rming previous data 
[18,19]. Addit ion of  the cyc looxygenase inhibitor,  indo- 
methac in  (10 txM), did not inf luence rates of  DNA synthe- 
sis or insul in secretion; nor  did it prevent the action of  
IL-1 [3. The indomethac in  concentrat ion chosen was identi- 
cal to that in other studies [12,14,15], and has been shown 
prev ious ly  to inh ib i t  islet p ros tag land in  synthes is  
[12,14,15]. No attempts were made in this study to assay 
for endogenous  prostaglandins or their  metabol i tes,  how- 
ever. The IL-1 [3 concentrat ion of  25 U /ml  has previously 
been shown to be maximal ly  effect ive in inhibit ing [3-cell 
mitogenesis  and insul in secretion in this system [19]. The 
physio logic IL-113 concentrat ion i the vicinity of the islets 
is not known, nor is the IL-I[3 concentrat ion in the in- 
f lamed islets in type-I  diabetes. However ,  since islet-in- 
f i l trating macrophages synthesize IL-1 [3 in type-1 diabetes 
[7], it can be assumed that the IL-II3 concentrat ion sur- 
rounding the [3-cells in type-I  diabetes may be quite 
s ignif icant (a l though probably  impossib le to assay). 
4. D iscuss ion  
The present study shows that exogenous prostaglandins 
of  the E-series cause long-term suppress ion of pancreat ic 
[3-cell mitogenesis  and insul in secretion. There are numer-  
ous reports indicat ing that prostaglandins funct ion as in- 
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hibitors of short-term (1-60 min) insulin secretion in vitro 
(reviewed in [14,15]), but the best of our knowledge this is 
the first report describing inhibition also in the long term 
by these eicosanoids. Since no direct measurements of
media prostaglandin levels were attempted, I can, natu- 
rally, not be sure that islets were exposed to the same 
prostaglandin concentrations throughout the 24 h exposure 
period. On the other hand, since insulin secretion were 
measured over 24 h and changes in DNA synthesis rates 
normally occur over 10-2.4 h, a detailed prostaglandin 
degradation study would not be meaningful. The prosta- 
glandins are readily synthesized from [3-cell arachidonic 
acid by cyclooxygenase and it is conceivable that they 
adversely influence insulin secretion and glucose home- 
ostasis in vivo. Indeed, experiments in intact animals and 
in humans revealed that prostaglandin fusion decreased 
the amount of insulin secreted in response to an intra- 
venous glucose challenge [14]. Certain cyclooxygenase 
inhibitors have also been reported not only to augment 
glucose-induced insulin responses in normal humans, but 
also to improve glucose disposal rates and glucose-sensi- 
tive insulin secretion in patients with type-II diabetes 
mellitus [14]. The direct suppressive ffects of prosta- 
glandins on long-term [3-cell mitogenesis and insulin re- 
lease may have significant pathophysiological ramifica- 
tions in diabetes, which is characterized by an impeded 
insulin secretory response to glucose [23], and can be 
ameliorated by expansion of the endogenous [3-cell mass 
[24]. 
The mechanisms by which prostaglandins exert their 
multifarious actions still remain largely elusive. To the 
best of my knowledge, no information is available on the 
cellular uptake of prostaglandins and indomethacin islet 
tissue. In other cell types cDNAs encoding thromboxane 
A 2 and prostaglandin EP 3 receptor subtypes have been 
cloned and characterized [25]. In [3-cells, prostaglandins 
also inhibit inositol phosphate generation and cyclic AMP 
formation [14,26], two events invariably connected to pro- 
motion of mitogenesis and insulin secretion [3,4,18,19]. 
Furthermore, PGE 2 was recently shown to activate a 
high-affinity GTPase in secretory granules of normal rat 
and human islets [27]. Germane to this, pertussis toxin 
pretreatment was found to partially alleviate the inhibition 
of phasic insulin secretion from a hamster insulinoma cell 
line [28], arguing in favor of heterotrimeric GTP-binding 
proteins partially conveying the short-term inhibitory ef- 
fect of prostaglandins in this cell line. In the long-term 
experiments involving normal 13-cells reported herein, no 
such protection by pertussis toxin pretreatment was 
recorded. The reason for this discrepancy remains elusive 
at this stage, but may be related to the long-term experi- 
mental conditions in which the toxin (presumably through 
cyclic AMP formation) in itself increased [3-cell prolifera- 
tion and insulin secretion (also noted previously [18,19]). 
The pertussis toxin concentration chosen (50 ng/ml) has 
in other studies [3] been shown to be more than sufficient 
to totally reverse suppression of [3-cell function, and has 
also been shown to ADP-ribosylate all available G-pro- 
teins in the islets after 24 h. 
There is compelling evidence lending support o a key 
effector ole for the cytokine IL-113 in the development of
type-1 diabetes mellitus. IL-113 is secreted from leukocytes 
infiltrating the islets early in the development of insulin- 
dependent diabetes mellitus [29] and IL-1 levels in serum 
are elevated in newly diagnosed iabetic patients [30]. 
IL-113 has been shown to exert both inhibitory and cyto- 
toxic actions on pancreatic islet cells in vitro [5-7,31,32], 
findings reproduced in the present study. Generation of the 
inflammatory mediators prostaglandins through the con- 
certed action of phospholipase A 2 and cyclooxygenase i  a 
consistent event after exposure to IL-113 [9-11]. Also in 
rodent [3-cells does IL-I evoke a marked but delayed 
increase in PGE 2 formation, the time course fitting the 
inhibitory phase of IL-1 action on insulin release [12]. 
More recently, it was shown that IL-113 induces a coopera- 
tive expression of nitric oxide synthase and cyclooxy- 
genase in rat islets, the activation of the latter enzyme 
apparently being mediated by nitric oxide [13], thus con- 
firming findings in other tissues [33]. The finding that 
exogenous prostaglandins mimicked the inhibitory actions 
of IL-113 on 13-cell mitogenesis and insulin secretion en- 
gendered interest in the possibility that endogenous prosta- 
glandins indeed convey the suppressive signal by the 
cytokine, rather than merely being coexpressed. However, 
the data in Fig. 3 showing that the cyclooxygenase in- 
hibitor indomethacin failed to influence the inhibitory ef- 
fects of IL-113 argues against his possibility. This finding 
also confirms results from previous tudies [12,34,35]. 
It is concluded that prostaglandins suppress [3-cell mito- 
genesis and long-term insulin secretion without participa- 
tion of pertussis-toxin sensitive GTP-binding proteins. Al- 
though their synthesis is increased by IL-l[3, prosta- 
glandins eemingly do not convey the inhibitory actions of 
this cytokine in the 13-ce11. It is possible that locally 
produced prostaglandins may exert critical regulatory ac- 
tions on [3-cell growth and function in vivo. 
Acknowledgements 
~,.S. is a recipient of the 1994 Eli Lil ly/EASD Re- 
search Fellowship in Diabetes and Metabolism. I thank Dr. 
Klaus Bendtzen for kindly donating IL-1 [3, and the Upjohn 
Company for graciously supplying prostaglandins. The 
skilful technical assistance by Elvi Sandberg is gratefully 
acknowledged. Financial support was received from the 
Swedish Society of Medicine, the Nordic Insulin Fund, 
Barndiabetesfonden, ~,ke Wiberg's Foundation, Syskonen 
Svensson's Fund and Fredrik and Inger Thuring's Founda- 
tion. 
110 /~. Sj6holm / Biochimica et Biophysica Acta 1313 (1996) 106-110 
References 
[1] Hellerstr~Sm, C. and Swenne, I. (1985) in The Diabetic Pancreas, 2nd 
ed. (Volk, B.W. and Arquilla, E.R., eds.), New York, Plenum, pp. 
53-79. 
[2] Hellerstrtim, C., Andersson, A., Swenne, I., Welsh, M., Welsh, N. 
and SjiSholm, ,~. (1988) in Nobel Symposium-Pathogenesis of Non- 
Insulin Dependent Diabetes Mellitus (Efendic', S. and Grill, V., 
eds.), Raven Press, New York, pp. 79-91. 
[3] Sjtiholm, A. (1992)FEBS Lett. 311, 85-90, 
[4] Sjtiholm, ~. (1993) Am. J. Physiol. 264, C501-C518. 
[5] McDaniel, M.L., Hughes, J.H., Wolf, B.A., Easom, R.A. and Turk, 
J.W. (1988) Diabetes 37, 1311-1315. 
[6] Ling, Z., In t'Veld, P.A. and Pipeleers, D.G. (1993) Diabetes 42, 
56-65. 
[7] Bendtzen, K. (1989) Autoimmunity 2, 177-189. 
[8] Eisenbarth, G.S. (1986) N. Engl. J. Med. 314, 1360-1368. 
[9] Kunkel, S.L., Chensue, W. and Phan, S.H. (1986) J. Immunol. 136, 
186-192. 
[10] Rossi, V., Breviario, F., Ghezza, P., Dejana, E. and Mantovani, A. 
(1985) Science 229, 1174-1176. 
[11] Shimizu, H., Uehara, Y., Sato, N., Shimomura, Y., Mori, M. and 
Kobayashi, I. (1992) Eur. J. Pharmacol. 222: 279-282. 
[12] Hughes, J.H., Easom, R.A., Wolf, B.A., Turk, J. and McDaniel, 
M.L. (1989) Diabetes 38, 1251-1257. 
[13] Corbett, J.A., Kwon, G., Turk, J. and McDaniel, M.L, (1993) 
Biochemistry 32, 13767-13770. 
[14] Robertson, R,P. (1979) Diabetes 28, 943-948. 
[15] Robertson, R,P. (1983) Diabetes 32, 231-234. 
[16] Sandier, S., Bendtzen, K., Eizirik, D.L., Sj/Sholm, ]~. and Welsh, N. 
(1989) Immunol. Lett. 22, 267-272. 
[17] Hellerstrtim, C., Lewis, N.J., Borg, H., Johnson, R. and Freinkel, N. 
(1979) Diabetes 28, 769-776. 
[18] SjiSholm, ,~. (1991) FEBS Lett. 289, 249-252. 
[19] Sj~holm, ~,. (1992) Am. J. Physiol. 263, C114-C120. 
[20] Swenne, I. (1984) in Methods in Diabetes Research, Vol I, Labora- 
tory Methods, Part B. (Larner, J. and Pohl, S., eds.) Wiley, pp. 
176-191. 
[21] Sj~Sholm, ,~., Welsh, N., Hoftiezer, V., Bankston, P.W. and Heller- 
strum, C. (1991) Biochem. J. 277, 533-540. 
[22] Grill, V., Pigon, J., Hartling, S.G., Binder, C. and Efendic', S. 
(1990) Metabolism 39, 251-258. 
[23] Efendic', S., Luft, R. and Wajngot, A. (1984) Endocrine Rev. 5, 
395-410. 
[24] Rosenberg, L. and Vinik, A.I. (1992) In: Pancreatic islet cell regen- 
eration and growth. Vinik, A.I., ed. pp. 95-104, Plenum Press, New 
York. 
[25] Piomelli, D. (1993) Curt. Opin. Cell Biol. 5, 274-280. 
[26] Laychock, S.G. (1990) Mol. Pharmacol. 37, 928-936. 
[27] Kowluru, A. and Metz, S.A. (1994) Biochem. J. 297, 399-406. 
[28] Robertson, R.P., Seaquist, E.R. and Walseth, T.F. (1991) Diabetes 
40, 1-6. 
[29] Jiang, Z. and Woda, B.A, (1991) J. Immunol. 146, 2990-2994. 
[30] Hussain, M.J., Peakman, M., Leslie, R.D.G., Viberti, G.C., Watkins, 
P.J. and Vergani, D. (1990) Diabetic Med. 7 (suppl. 1), 2A. 
[31] Jafarian-Tehrani, M., Amrani, A., Homo-Delarce, F., Marquette, C., 
Dardenne, M. and Haour, F. (1995) Endocrinology 136, 609-613. 
[32] Corbett, J.A. and McDaniel, M.L. (1995) J. Exp. Med. 181,559-568. 
[33] Salvemini, D., Misko, T.P., Masferrer, J.L., Seibert, K., Currie, 
M.G. and Needleman, P. (1993) Proc. Natl. Acad. Sci. USA 90, 
7240-7244. 
[34] Sandler, S., Bendtzen, K., Borg, L.A.H., Eizirik, D.L., Strandell, E., 
Welsh, N. (1989) Endocrinology 124,1492-1501. 
[35] Dayer-M&roz, M.-D., Wollheim, C.B., Seckinger, P. and Dayer, 
J.-M. (1989) J. Autoimmun. 2, 163-171. 
